Gardiner & Theobald Completes Long-Term Strategic Partnership With Hennick & Company
August 06, 2024 10:05 ET
|
Hennick & Company; Gardiner & Theobald LLP
Gardiner & Theobald, an independent construction and property consultancy, completes long-term strategic partnership with Hennick & Company.
Compass Therapeutics Completes Patient Enrollment in COMPANION-002, a Randomized Study of CTX-009 in Combination with Paclitaxel, and Provides an Update on the Development Plan in Biliary Tract Cancer
August 06, 2024 08:00 ET
|
Compass Therapeutics
Completed enrollment of the planned 150 patients in COMPANION-002, a Phase 2/3 trial of CTX-009 plus paclitaxel versus paclitaxel in patients with previously treated, unresectable advanced Metastatic...
SCCT 2024: HeartFlow to Present New Data on Coronary Artery Disease Management with Coronary Computed Tomography Angiography
July 16, 2024 12:00 ET
|
HeartFlow Holding, Inc.
MOUNTAIN VIEW, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- HeartFlow, a leader in non-invasive artificial intelligence (AI) heart care solutions, today announced it will be presenting new findings on...
OKYO Pharma to Initiate Neuropathic Corneal Pain Trial for OK-101
July 11, 2024 07:00 ET
|
OKYO Pharma LTD
Phase 2 randomized, placebo-controlled trial in neuropathic corneal pain (NCP) patients planned to begin in Q3, 2024OK-101 is believed to be the first IND clearance granted by FDA for a drug to begin...
2X Announces Expansion of Marketing Strategic Consulting Practice to Fuel Clients Exponential Business Growth
July 10, 2024 10:00 ET
|
2X
MALVERN, Pa., July 10, 2024 (GLOBE NEWSWIRE) -- Building on its extraordinary organic success, 2X, the world’s largest B2B marketing-as-a-service (MaaS) firm, proudly announces the expansion of its...
Kymera Announces Expansion of KT-474 (SAR444656) HS and AD Phase 2 Studies Following Interim Review of Safety and Efficacy
July 08, 2024 16:05 ET
|
Kymera Therapeutics, Inc.
WATERTOWN, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using...
Saudi Arabia Digital Transformation Consulting Services Market 2024: Vision 2030 Goals Spearheaing Growth - Competition, Forecast & Opportunities to 2029
July 05, 2024 04:18 ET
|
Research and Markets
Dublin, July 05, 2024 (GLOBE NEWSWIRE) -- The "Saudi Arabia Digital Transformation Consulting Services Market, By Region, By Competition, Forecast & Opportunities, 2019-2029F" report has been...
Forbion Strengthens US Presence, Hiring Biotech Industry Leader and Opening Boston Office
June 27, 2024 07:00 ET
|
Forbion
Josh Brumm, previously CEO of Dyne Therapeutics, appointed as General Partner at Forbion. Brumm to be located at Forbion's new Boston office.
United States Management Consulting Services Markets, 2019-2023 & 2024-2029: Strategy Consulting to Drive Demand, Healthcare Drives Market Growth
June 19, 2024 07:03 ET
|
Research and Markets
Dublin, June 19, 2024 (GLOBE NEWSWIRE) -- The "US Management Consulting Services - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029" report has been added to ...
Compass Minerals International, Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
June 17, 2024 13:57 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 17, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Compass Minerals International,...